Defining and Characterizing the Progression of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is a progressive disease in which the risks of myocardial infarction, stroke, microvascular events, and mortality are all strongly associated with hyperglycemia (1). The disease course is primarily characterized by a decline in �-cell function and worsening of insulin resistance. The process is manifested clinically by deteriorations in multiple parameters, including A1C, fasting plasma glucose (FPG), and postprandial glucose levels. In this review, we will evaluate our current understanding of the role played by deteriorating �-cell function and other abnormalities linked with the progression of type 2 diabetes. An improved understanding of these abnormalities may provide the scientific groundwork for novel therapies that may help achieve and maintain good glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, the essential oil extracted from CW, primarily comprising esters (58.3%) and ketones (33.5%), has also demonstrated notable free radical scavenging activity and antioxidant potential [49].”
From Research Progress in Coconut Water: A Review of Nutritional Composition, Biological Activities, and Novel Processing Technologies (2025) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Regardless of the treatment regime, longitudinal studies in humans have demonstrated that beta-cell function generally deteriorates over time.49,50”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Following the induction of insulin resistance, islet beta-cells can maintain normoglycaemia and metabolic homeostasis by increasing their secretion of insulin and/or by increasing their number.49,96,97”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“The gradual decline in islet beta-cell number and function results in insulin levels becoming too low to promote metabolic homeostasis and T2D results.49,91”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Obesity has been estimated to induce an ~50% increase in islet beta-cell volume due to increased neogenesis.49”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 201–300 of 574
Large-Scale Functional Genomics Screen to Identify Modulators of Human β-Cell Insulin Secretion
Szczerbinska, I., Tessitore, A., Hansson, L., Agrawal, A., Lopez, A. R., Helenius, M., Malinowski, A. R., Gilboa, B., Ruby, M. A., Gupta, R., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10010103 · Cited by 20
Piotrowska, K., Zgutka, K., Tkacz, M., & Tarnowski, M. (2023) · Antioxidants · doi:10.3390/antiox12081488 · Cited by 20
Kashiwagi, K., Inaishi, J., Kinoshita, S., Wada, Y., Hanashiro, S., Shiga, K., Kitazawa, M., Tsutsumi, S., Yamakawa, H., Irie, J., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291923 · Cited by 18
Genetic factors and the role of pancreatic amylase in the pathogenesis of type 2 diabetes
Abdulkareem, M. A., Owolabi, B., Saheed, E. S., Aromolaran, R. F., Bashiru, R. M., Jumah, T. A., Chijioke, D. U., Amaechi, O. J., Adeleke, F. C., Charles, O. O., et al. (2024) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-024-00505-6 · Cited by 17
Lejawa, M., Goławski, M., Fronczek, M., Osadnik, T., Paneni, F., Ruscica, M., Pawlas, N., Lisik, M., & Banach, M. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02389-7 · Cited by 20
Obesity and type 2 diabetes mellitus: insights from skeletal muscle extracellular matrix remodeling
Wu, L., & Coletta, D. K. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00154.2024 · Cited by 18
Li, H., Xu, J., & Fan, X. (2014) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2014.12.004 · Cited by 17
Baumert, J. J., Meisinger, C., Lukaschek, K., Emeny, R. T., Rückert, I., Kruse, J., & Ladwig, K. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-87 · Cited by 20
Oxamate Enhances the Anti-Inflammatory and Insulin-Sensitizing Effects of Metformin in Diabetic Mice
Wu, M., Ye, W., Zheng, Y., & Zhang, S. (2017) · Pharmacology · doi:10.1159/000478909 · Cited by 17
González-Aldaco, K., Román, S., Torres-Reyes, L. A., & Panduro, A. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s268329 · Cited by 19
Bone Marrow Stem Cell as a Potential Treatment for Diabetes
Li, M., & Ikehara, S. (2013) · Journal of Diabetes Research · doi:10.1155/2013/329596 · Cited by 20
Curtis, L. R., Humayun, M. A., Walker, J., Hampton, K., & Partridge, H. (2016) · Practical Diabetes · doi:10.1002/pdi.2018 · Cited by 17
Wang, T., Zhang, F., Wang, X., Li, X., Ling, H., Lv, D., Yin, X., & Lü, Q. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13134 · Cited by 39
Once-weekly Insulin Icodec as Compared to Once-daily Basal Insulins: A Meta-analysis
Mukhopadhyay, P., Chatterjee, P., Pandit, K., Sanyal, D., & Ghosh, S. K. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.11.004 · Cited by 16
Diabetes Pharmacotherapy in 2012: Considerations in Medication Selection
Cornell, S. A., & Dorsey, V. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.07.2571 · Cited by 17
Dapagliflozin in type 2 diabetes: effectiveness across the spectrum of disease and over time
Parikh, S. J., Wilding, J. P. H., Jabbour, S. A., & Hardy, E. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12531 · Cited by 16
Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect
Suissa, S. (2018) · Diabetes Care · doi:10.2337/dc17-1059 · Cited by 16
Rahman, S. S., Yasmin, N., Kamruzzaman, M., Islam, M. R., Karim, M. R., & Rouf, S. M. A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.055 · Cited by 16
Jeon, J. Y., Ha, K. H., & Kim, D. J. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0057 · Cited by 20
Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats
Singh, H., Ganneru, S., Malakapalli, V., Chalasani, M., Nappanveettil, G., Bhonde, R. R., & Venkatesan, V. (2014) · Islets · doi:10.1080/19382014.2014.998099 · Cited by 16
Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment
Fonseca, V. A., & Haggar, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.17 · Cited by 16
Self-citationHoenig, M. E., Traas, A. M., & Schaeffer, D. J. (2013) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.243.9.1302 · Cited by 16
Liljedahl, L., Pedersen, M. H., Norlin, J., McGuire, J. N., & James, P. (2016) · Clinical Proteomics · doi:10.1186/s12014-016-9123-z · Cited by 16
Marshall, C. J., Adams, S. R., Dyer, W., & Schmittdiel, J. A. (2017) · Women s Health Issues · doi:10.1016/j.whi.2017.06.001 · Cited by 16
Leguina‐Ruzzi, A., & Valderas, J. P. (2016) · Dermato-Endocrinology · doi:10.1080/19381980.2016.1267078 · Cited by 15
Kaewbut, P., Kosachunhanun, N., Phrommintikul, A., Chinwong, D., Hall, J. J., & Chinwong, S. (2021) · Medicina · doi:10.3390/medicina58010063 · Cited by 17
Kolling, L. J., Khan, K. M., Wang, R., Pierson, S. R., Hartman, B., Balasubramanian, N., Guo, D., Rahmouni, K., & Marcinkiewcz, C. A. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115951 · Cited by 16
Gaitán, J. M., WELTMAN, A. L., & Malin, S. K. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8314852 · Cited by 16
Murao, S., Murao, K., Nagata, T., Shimizu, M., & Miyai, Y. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13753 · Cited by 16
Tsai, H., Shen, C., Ho, C., Hsu, S., Tantoh, D. M., Nfor, O. N., Chiu, S., Chou, Y., & Liaw, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03269-y · Cited by 14
Using Dextran-encapsulated Gold Nanoparticles As Insulin Carriers to Prolong Insulin Activity
Lee, K.-C., Chen, W.-J., & Chen, Y. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0019 · Cited by 16
DeFronzo, R. A., Lee, C. S., & Köhler, S. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0724-y · Cited by 14
Everitt, B., Harrison, H. C., NIKKEL, C. C., Laswell, E. M., & Chen, A. M. H. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2018.09.016 · Cited by 14
Coelho, G. D. P., Martins, V. S., do Amaral, L. V., Novaes, R. D., Sarandy, M. M., & Gonçalves, R. V. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/3537163 · Cited by 14
Aroda, V. R., Arulandu, J. R., & Cannon, A. J. (2018) · Clinical Diabetes · doi:10.2337/cd17-0065 · Cited by 13
Choucair, I., Mallela, D. P., Hilser, J. R., Hartiala, J., Nemet, I., Gogonea, V., Li, L., Lusis, A. J., Fischbach, M. A., Tang, W. H. W., et al. (2024) · Diabetes · doi:10.2337/db23-0676 · Cited by 15
A-Elgadir, T. M. E., Shati, A. A., Alqahtani, S. A., Ebrahim, H. A., Almohaimeed, H. M., ShamsEldeen, A. M., Haidara, M. A., Kamar, S. S., Dawood, A. F., & El-Bidawy, M. H. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112280 · Cited by 14
GLP-1 and Its Role in Glycogen Production: A Narrative Review
Lotosky, J., Jean, X., Altankhuyag, A., Khan, S. R., Bernotas, A., Sharafshah, A., Blum, K., Posner, A. R., & Thanos, P. K. (2025) · Biomedicines · doi:10.3390/biomedicines13071610 · Cited by 17
Schwartz, S. S., & Ahmed, I. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1151774 · Cited by 15
Can Newer Anti-Diabetic Therapies Delay the Development of Diabetic Nephropathy?
Aziz, S., Ghadzi, S. M. S., Sulaiman, S. A. S., Hanafiah, N. H. M., & Harun, S. N. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_497_21 · Cited by 13
Szépkúti, S., Bandur, S., Kovács, G., Ferenci, T., Svébis, M. M., Turbucz, P., & Tabák, Á. G. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01139-8 · Cited by 15
Gottlieb, A., Yanover, C., Cahan, A., & Goldschmidt, Y. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000435 · Cited by 17
Cheng, Y. J., Kahn, H. S., Gregg, E. W., Imperatore, G., & Geiss, L. S. (2010) · Diabetologia · doi:10.1007/s00125-010-1800-2 · Cited by 14
Kellow, N. J., Savige, G. S., & Khalil, H. (2011) · Australian Journal of Rural Health · doi:10.1111/j.1440-1584.2011.01222.x · Cited by 17
Giugliano, D., Longo, M., Scappaticcio, L., Caruso, P., Gicchino, M., Petrizzo, M., Bellastella, G., Maiorino, M. I., & Esposito, K. (2023) · Endocrine · doi:10.1007/s12020-023-03547-9 · Cited by 12
Utzschneider, K. M., Younes, N., Butera, N. M., Balasubramanyam, A., Bergenstal, R. M., Barzilay, J. I., Desouza, C. V., DeFronzo, R. A., Elasy, T. A., Krakoff, J. A., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1059 · Cited by 12
Jiang, Y., Wang, L., Dong, Z., Xia, B.-T., & Pang, S. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13563 · Cited by 10
Lajara, R., Aguilar, R. B., Hehnke, U., Woerle, H., & von Eynatten, M. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.020 · Cited by 12
Sehgal, S., & Khanolkar, M. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0100-8 · Cited by 12
Frías, J. P., González-Gálvez, G., JOHNSSON, E. K., Maaske, J., Testa, M. A., Simonson, D. C., Dronamraju, N., García‐Sánchez, R., & Peters, A. L. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13997 · Cited by 15
Statins are associated with new onset type 2 diabetes mellitus (T2DM) in Medicare patients ≥65 years
Tangelloju, S., Little, B. B., Esterhay, R. J., Brock, G. N., & Lajoie, S. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3310 · Cited by 13
The Effects of Photobiomodulation on Bone Defect Repairing in a Diabetic Rat Model
Lee, J.-H., Kong, S. C., Chen, C., Lin, Y., Lee, K.-T. D., & Wang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011026 · Cited by 16
Mishra, S., Verma, N., Bhattacharya, S., Usman, K., Himanshu, D., Singh, P., Anjum, B., & Verma, N. (2015) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20150035 · Cited by 13
Archontogeorgis, K., Παπάνας, Ν., Rizos, E. C., Nena, E., Zissimopoulos, A., Tsigalou, C., Voulgaris, A., Mikhailidis, D. P., Elisaf, M., Froudarakis, Μ. E., et al. (2019) · Medicina · doi:10.3390/medicina55050174 · Cited by 12
Elshareif, N., Gornick, E. S., Gavini, C. K., Aubert, G., & Mansuy‐Aubert, V. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1238120 · Cited by 13
Allende-Vigo, M. Z. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3182211bae · Cited by 17
Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
Lang, B., Josephy, T., Micks, E., McCoy, E., & Prager, S. (2018) · Clinical Diabetes · doi:10.2337/cd17-0028 · Cited by 11
Li, D., Zou, H., Yin, P., Li, W., He, J., Wang, S., Huang, L., Shao, S., Chen, Y., Yang, Y., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14217 · Cited by 11
Liu, J.-J., Gurung, R. L., Liu, S., Yiamunaa, M., Lee, J., Ang, K., Tavintharan, S., Tang, W. E., Sum, C. F., & Lim, S. C. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101238 · Cited by 11
The Transgenerational Transmission of the Paternal Type 2 Diabetes-Induced Subfertility Phenotype
Žatecká, E., Bohuslavová, R., Valášková, E., Margaryan, H., Elzeinová, F., Kubatova, A., Hylmarova, S., Pěknicová, J., & Pavlínková, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.763863 · Cited by 11
OKAZAKI, K., Takahashi, N., Shingaki, T., Perez‐Nieves, M., & Stuckey, H. L. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.02.009 · Cited by 11
The chicken or the egg? Does glycaemic control predict cognitive function or the other way around?
Ganmore, I., & Beeri, M. S. (2018) · Diabetologia · doi:10.1007/s00125-018-4689-9 · Cited by 11
Menon, A., Fatehi, F., Ding, H., Bird, D., Karunanithi, M., Gray, L., & Russell, A. W. (2019) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2019-100068 · Cited by 11
Nazu, N. A., Wikström, K., Lamidi, M., Lindström, J., Tirkkonen, H., Rautiainen, P., & Laatikainen, T. K. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108312 · Cited by 12
Yunn, N.-O., Kim, J. J., Kim, Y., Leibiger, I. B., Berggren, P., & Ryu, S. H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.005 · Cited by 11
Prediabetes and diabetes prevalence in the Workers’ Oral Health Study
Montero, E., Carasol, M., Fernández‐Meseguer, A., Calvo‐Bonacho, E., García‐Margallo, M. T., Sanz, M., & Herrera, D. (2019) · Clinical Oral Investigations · doi:10.1007/s00784-019-02875-3 · Cited by 15
Паневин, Т. С., Елисеев, М. С., Shestakova, M. V., & Nasonov, E. L. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.05.000633 · Cited by 12
Haluzík, M., Taybani, Z. J., Araszkiewicz, A., Cerghizan, A., Mankovsky, B., Zuhdi, A., & Malecki, M. T. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01610-w · Cited by 12
Bush, J., Iwuamadi, I., Han, J., Schibli, D. J., Goodlett, D. R., & Deehan, E. C. (2024) · Metabolites · doi:10.3390/metabo14100536 · Cited by 11
Pearson, E. R., Prato, S. D., Pavo, I. J., Franco, D. R., Zheng, J., Nicolay, C., Hemmingway, A., Wiese, R. J., & Kahn, S. E. (2025) · Diabetes · doi:10.2337/db25-0276 · Cited by 12
Harris, M. L., Kuzulugil, D., Parsons, M., Byles, J., & Acharya, S. (2020) · Health & Social Care in the Community · doi:10.1111/hsc.13254 · Cited by 11
Xiang, A. S., Szwarcbard, N., Gašević, D., Earnest, A., Pease, A., Andrikopoulos, S., Wischer, N., Davis, W. A., & Zoungas, S. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14506 · Cited by 11
Bobryk, M. I., Tutchenko, T. М., Сідорова, І. В., Бурка, О. А., Krotik, O. І., & Serbeniuk, A. (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.62.97-103 · Cited by 15
Wang, X., Lin, Y., Xiong, Y., Zhang, S., He, Y., He, Y., Zhang, Z., Plasek, J. M., Zhou, L., Bates, D. W., et al. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01915-5 · Cited by 12
Xiao, X., Erukainure, O. L., & Islam, M. S. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.018 · Cited by 10
Mewborn, E., Tolley, E. A., Wright, D. B., Doneen, A. L., Harvey, M., & Stanfill, A. G. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100625 · Cited by 10
Hernández-Martín, M., Macho‐González, A., Garcimartín, A., López‐Oliva, M. E., Bocanegra, A., Redondo‐Castillejo, R., Bastida, S., Benedí, J., & Sánchez-Muniz, F. J. (2024) · Food & Function · doi:10.1039/d3fo04103d · Cited by 10
Etiologies underlying subtypes of long-standing type 2 diabetes
Bayoumi, R., Farooqi, M. H., Alawadi, F., Hassanein, M. M., Osama, A., Mukhopadhyay, D., Abdul, F., Sulaiman, F., Dsouza, S., Mulla, F., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304036 · Cited by 11
Ramya, K., Amreen, K., & Goel, S. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.111029 · Cited by 10
Mayer, C., Bergholdt, R., Cucak, H., Rolin, B., Sams, A. G., & Rosendahl, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131306 · Cited by 10
Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials
Sjöstrand, M., Wei, C., Cook, W., Johnsson, K. M., Pollack, P. S., Stahre, C., & Hirshberg, B. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0261-8 · Cited by 10
Kim, K., Unni, S. K., Brixner, D. I., Thomas, S. M., Olsen, C. J., Sterling, K. L., Mitchell, M., & McAdam‐Marx, C. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13694 · Cited by 13
Fulcher, G. R., Jarlov, H., Piltoft, J. S., Singh, K. P., Liu, L., Mohamed, M., Nicodemus, N. A., Aljaser, S., & Kok, A. (2021) · Endocrine · doi:10.1007/s12020-021-02887-8 · Cited by 11
Sanni, A. A., Blanks, A. M., Derella, C. C., Horsager, C., Crandall, R. H., Looney, J. C., Sanchez, S., Norland, K., Ye, B., Thomas, J., et al. (2022) · Physiological Reports · doi:10.14814/phy2.15208 · Cited by 10
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac111.81418155 · Cited by 15
Mewborn, E., & Stanfill, A. G. (2023) · Clinical Medicine Insights Cardiology · doi:10.1177/11795468231170779 · Cited by 12
Hannon, T. S., Kirkman, M. S., Patel, Y. R., Considine, R. V., & Mather, K. J. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2553 · Cited by 10
The Role of the Kidney in Hyperglycemia: A New Therapeutic Target in Type 2 Diabetes Mellitus
Hinnen, D. (2013) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e318245633e · Cited by 10
Hornbak, M., Allin, K. H., Jensen, M. L., Lau, C. J., Witte, D. R., Jørgensen, M. E., Sandbæk, A., Lauritzen, T., Andersson, Å., Pedersen, O. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104837 · Cited by 9
Karahan, H. G., Çetin, O., Gök, M., Akın, H. F., Vural, A., & Kayalı, C. (2023) · Joint Diseases and Related Surgery · doi:10.52312/jdrs.2023.818 · Cited by 9
Palmer, R., Neiberg, R. H., Beavers, K. M., Kahn, S. E., Houston, D. K., Wagenknecht, L. E., Johnson, K., Pownall, H. J., Espeland, M. A., & For the Action for Health in Diabetes (Look AHEAD) Aging Study Group (2025) · Obesity · doi:10.1002/oby.24242 · Cited by 9
Dapagliflozin in the treatment of patients with type 2 diabetes presenting with high baseline A1C
SKOLNIK, N., Bonnes, H., Yeh, H., & Katz, A. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1173514 · Cited by 12
Gallardo‐Rincón, H., Saucedo-Martínez, R., Mújica‐Rosales, R., Lee, E. M., Israel, A., Torres-Beltrán, B., Quijano-González, Ú., Atkinson, E. R., Kuri-Morales, P. A., & TAPIA-CONYER, R. C. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s137891 · Cited by 10
Mueller, A. M., Meier, C. R., Jick, S. S., & Schneider, C. (2022) · Pancreatology · doi:10.1016/j.pan.2022.03.012 · Cited by 10
Lim, L., Lau, E. S. H., Ozaki, R., So, T., Wong, R. Y. M., Chow, E., Ronald, C. W., Luk, A. O. Y., Chan, J. C. N., & Kong, A. P. S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110138 · Cited by 9
Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
Neumiller, J. J. (2014) · Clinical Diabetes · doi:10.2337/diaclin.32.4.170 · Cited by 11
Lu, C., Chen, Y., Chen, S., Hsu, Y., Lin, C., Tsao, J.-W., Juan, Y., Yang, J., & Tsai, F. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6152 · Cited by 9
Endocrine, nutritional, and metabolic diseases
Nesterova, A. P., Климов, Е. А., Жаркова, М. С., Sozin, S., Соболев, В. В., Ivanikova, N. V., Shkrob, M., & Yuryev, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817086-1.00004-x · Cited by 9
Excessive iron inhibits insulin secretion via perturbing transcriptional regulation of SYT7 by OGG1
Zhao, X., Ma, Y., Shi, M., Huang, M., Xin, J., Ci, S., Chen, M., Jiang, T., Hu, Z., He, L., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04802-y · Cited by 11
Lum, Z. K., Siaw, M. Y. L., Lee, M. J. X., Koh, Z., Zhang, P. Q., Eng, S. K., Tan, S. C., & Lee, J. V. (2019) · Quality of Life Research · doi:10.1007/s11136-019-02253-2 · Cited by 9
Metadata
- Authors
- Fonseca, V. A.
- Affiliations
- Tulane University (US)
- Corresponding author
- Fonseca, Vivian A.
- ORCID
- Fonseca, Vivian A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S151-S156
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811457
- OpenAlex
- W2128050336
- Cited by
- 573
- References
- 40
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 50 · 2023: 51 · 2022: 41 · 2021: 51 · 2020: 54 · 2019: 50 · 2018: 43 · 2017: 37 · 2016: 43 · 2015: 37 · 2014: 23 · 2013: 17 · 2012: 7
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes progression, beta-cell function decline, insulin resistance, hyperglycemia, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, microvascular complications, cardiovascular risk
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin Resistance, Obesity, Prediabetic State, Weight Gain, Disease Progression, Postprandial Period, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.